Business Description
CanSino Biologics Inc
ISIN : CNE100004BM0
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.61 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.43 | |||||
Debt-to-EBITDA | -2.54 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.22 | |||||
Beneish M-Score | -16.89 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 152.5 | |||||
3-Year EBITDA Growth Rate | -57.3 | |||||
3-Year EPS without NRI Growth Rate | -44.6 | |||||
3-Year FCF Growth Rate | -21.2 | |||||
3-Year Book Growth Rate | -7.1 | |||||
Future 3-5Y Total Revenue Growth Rate | 62.86 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.57 | |||||
9-Day RSI | 50.39 | |||||
14-Day RSI | 53.9 | |||||
6-1 Month Momentum % | 43.84 | |||||
12-1 Month Momentum % | -9.69 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.38 | |||||
Quick Ratio | 2.19 | |||||
Cash Ratio | 1.85 | |||||
Days Inventory | 263.25 | |||||
Days Sales Outstanding | 400.94 | |||||
Days Payable | 77.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 3.06 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 11.65 | |||||
Operating Margin % | -145.64 | |||||
Net Margin % | -142.92 | |||||
FCF Margin % | -108.79 | |||||
ROE % | -16.02 | |||||
ROA % | -9.54 | |||||
ROIC % | -15.92 | |||||
ROC (Joel Greenblatt) % | -30.2 | |||||
ROCE % | -12.74 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 11.94 | |||||
PB Ratio | 1.45 | |||||
Price-to-Tangible-Book | 1.49 | |||||
EV-to-EBIT | -11.98 | |||||
EV-to-EBITDA | -11.98 | |||||
EV-to-Revenue | 16.85 | |||||
EV-to-FCF | -16.18 | |||||
Price-to-Net-Current-Asset-Value | 5.01 | |||||
Price-to-Net-Cash | 16.22 | |||||
Earnings Yield (Greenblatt) % | -8.35 | |||||
FCF Yield % | -5.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
CanSino Biologics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 609.516 | ||
EPS (TTM) (Â¥) | -3.513 | ||
Beta | 1.93 | ||
Volatility % | 59.64 | ||
14-Day RSI | 53.9 | ||
14-Day ATR (Â¥) | 3.027971 | ||
20-Day SMA (Â¥) | 66.133 | ||
12-1 Month Momentum % | -9.69 | ||
52-Week Range (Â¥) | 37.12 - 85.58 | ||
Shares Outstanding (Mil) | 247.45 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
CanSino Biologics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
CanSino Biologics Inc Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
CanSino Biologics Inc Frequently Asked Questions
What is CanSino Biologics Inc(SHSE:688185)'s stock price today?
When is next earnings date of CanSino Biologics Inc(SHSE:688185)?
Does CanSino Biologics Inc(SHSE:688185) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |